In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp. (Q39652771)

13 September 2017

In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp. (English)

1 reference

13 September 2017

1 reference

6

Thomas F Patterson

1 reference

13 September 2017

William R. Kirkpatrick

4

object named as

William R Kirkpatrick

1 reference

13 September 2017

Sofia Perea

1

1 reference

13 September 2017

Gloria Gonzalez

2

1 reference

13 September 2017

Annette W Fothergill

3

1 reference

13 September 2017

Michael G Rinaldi

5

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

Antimicrobial Agents and Chemotherapy

13 September 2017

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

13 September 2017

46

1 reference

13 September 2017

9

1 reference

13 September 2017

3039-3041

1 reference

In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

13 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127429

Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127429

Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127429

In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127429

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127429

Current and emerging azole antifungal agents

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127429

Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127429

In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127429

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127429

In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127429

In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127429

Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127429

In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127429

21 August 2018

Invasive aspergillosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12183266

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.46.9.3039-3041.2002

1 reference

13 September 2017

1 reference

13 September 2017

1 reference